Cargando…

Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report

BACKGROUND: Calcium channel blockers (CCB), the first accepted treatment, is effective only in a small number of idiopathic pulmonary arterial hypertension (I-PAH) patients with vasoreactivity [these patients are identified by a positive acute pulmonary vasoreactive test (AVT) response]. While the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirakawa, Kyoko, Aoki, Tatsuo, Tsuji, Akihiro, Ogo, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446687/ https://www.ncbi.nlm.nih.gov/pubmed/36072422 http://dx.doi.org/10.1093/ehjcr/ytac351

Ejemplares similares

Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension
por: Suzuki, Sho, et al.
Publicado: (2022)

Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension
por: Asano, Ryotaro, et al.
Publicado: (2021)

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension
por: Wu, Yan, et al.
Publicado: (2022)

The Long-Term Response to Treatment with Calcium Channel Blockers in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Kiani, Azam, et al.
Publicado: (2023)

Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers
por: Tamura, Yuichi, et al.
Publicado: (2023)

Clinical response to calcium channel blockers in a hemodynamically unstable patient with reactive idiopathic pulmonary arterial hypertension
por: Kopec, Grzegorz, et al.
Publicado: (2017)

Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine)
por: Misumi, Kayo, et al.
Publicado: (2018)

Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension
por: Piloto, Bruna, et al.
Publicado: (2023)

Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension
por: Tsubata, Hideo, et al.
Publicado: (2023)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

An evaluation of vardenafil as a calcium channel blocker in pulmonary artery in rats
por: Minareci, Edibe, et al.
Publicado: (2014)

Successful balloon pulmonary angioplasty with gadolinium contrast media for a patient with chronic thromboembolic pulmonary hypertension and iodine allergy
por: Nakamura, Tomohisa, et al.
Publicado: (2016)

Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Fukui, Shigefumi, et al.
Publicado: (2016)

The changing landscape of chronic thromboembolic pulmonary hypertension management
por: Madani, Michael, et al.
Publicado: (2017)

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
por: Lang, Irene, et al.
Publicado: (2017)

Recent advances in pulmonary arterial hypertension
por: Wilkins, Martin R., et al.
Publicado: (2018)

Advances in the management of pulmonary arterial hypertension
por: Deshwal, Himanshu, et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2019)

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
por: Redel-Traub, Gabriel, et al.
Publicado: (2022)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Editorial: Calcium and pulmonary hypertension
por: Li, Ji-Feng, et al.
Publicado: (2022)

Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension
por: Masaki, Takeshi, et al.
Publicado: (2021)

Pulmonary arterial hypertension: Advances in pathophysiology and management
por: Chopra, Sandeep, et al.
Publicado: (2012)

Recent advances in the management of pulmonary arterial hypertension
por: Tsai, Halley, et al.
Publicado: (2016)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
por: Otani, Naoyuki, et al.
Publicado: (2022)

Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension
por: Peng, Chi, et al.
Publicado: (2021)

Left main coronary artery compression by a dilated main pulmonary artery and left coronary sinus of Valsalva aneurysm in a patient with heritable pulmonary arterial hypertension and FLNA mutation
por: Hirashiki, Akihiro, et al.
Publicado: (2017)

Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension
por: Liang, Shuxin, et al.
Publicado: (2022)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

Targeting ATP-Sensitive K(+) Channels to Treat Pulmonary Hypertension
por: Breen, Ellen, et al.
Publicado: (2022)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
por: Kawabata, Yutaka, et al.
Publicado: (2020)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

Ion channels as convergence points in the pathology of pulmonary arterial hypertension
por: Jouen-Tachoire, Thibault R. H., et al.
Publicado: (2021)

Transcriptomic profile of cationic channels in human pulmonary arterial hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2021)

Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
por: Graham, Brian B., et al.
Publicado: (2023)

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
por: Kuwana, Masataka, et al.
Publicado: (2023)

Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia
por: Kamada, Hiroyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_unlnrflthbpfdijj2ge9q1i8pc